Trials / Unknown
UnknownNCT05453591
Investigation of Urinary Biomarkers for the Detection of Breast Cancer
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- Novosanis NV · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The aim of this study is to investigate and possibly validate urinary biomarkers for breast cancer. During this study the focus will be on aberrations of selected genes as prognostic or predictive value has been shown for these genes in tissue, CTC or blood derived cfDNA. Proteins will be explored in urine as well. This is a prospective study in which urine samples will be collected from healthy volunteers and urine samples and a blood sample from cancer patients with breast cancer. The participants will be asked to provide a urine sample collected with the ColliPee® device and fill out an online questionnaire to collect usability data. Thereafter, the urine sample will be aliquoted to be used in the study to investigate the different urinary analytes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Colli-Pee UAS devices | Colli-Pee UAS device variants will be evaluated during this study |
Timeline
- Start date
- 2022-12-21
- Primary completion
- 2023-12-01
- Completion
- 2024-04-01
- First posted
- 2022-07-12
- Last updated
- 2023-03-24
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT05453591. Inclusion in this directory is not an endorsement.